Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind Multi-centre Trial (RAPID-I)
Status:
Suspended
Trial end date:
2023-04-30
Target enrollment:
Participant gender:
Summary
This study evaluates the effectiveness and safety of infliximab in the treatment of acute
pancreatitis in adults. A third of participants will receive one single dose of infliximab
via infusion, another third will receive a higher dose of infliximab via infusion and the
final third of participants will receive a placebo infusion.
Phase:
Phase 2
Details
Lead Sponsor:
Professor Robert Sutton
Collaborators:
Bangor University Clinical Trials Research Centre Liverpool Clinical Trials Centre Liverpool University Hospitals NHS Foundation Trust Medical Research Council Merck Sharp & Dohme Corp. National Institute for Health Research, United Kingdom Royal Liverpool and Broadgreen University Hospitals NHS Trust University of Liverpool